- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00112515
Modafinil in Treating Fatigue in Patients With Cancer
Pilot Study Evaluating the Safety and Efficacy of Modafinil in Improving Fatigue, Mood, Cognitive Ability, Functional Status, and Quality of Life of Cancer Patients
RATIONALE: Modafinil may help relieve fatigue and improve quality of life in patients with cancer.
PURPOSE: This clinical trial is studying how well modafinil works in treating fatigue in patients with cancer.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
OBJECTIVES:
Primary
- Determine the safety of modafinil in cancer patients.
- Determine the efficacy of this drug, in terms of improving fatigue, in these patients.
Secondary
- Determine the efficacy of this drug, in terms of improving mood, cognitive ability, functional status, and quality of life, in these patients.
OUTLINE: This is a nonrandomized, pilot study.
Patients receive oral modafinil once daily for 4 weeks in the absence of disease progression or unacceptable toxicity. Patients may receive additional modafinil at the discretion of the physician.
Fatigue, mood, cognition, functional status, and quality of life are assessed at baseline and in weeks 2 and 4.
After completion of study treatment, patients are followed at 30 days.
PROJECTED ACCRUAL: A total of 26 patients will be accrued for this study within 9 months.
Studietype
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Virginia
-
Charlottesville, Virginia, Forente stater, 22908
- University of Virginia Cancer Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
DISEASE CHARACTERISTICS:
- Diagnosis of cancer
- Brief Fatigue Inventory score ≥ 4
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- ECOG 1-3
Life expectancy
- At least 2 months
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Cardiovascular
- No history of left ventricular hypertrophy
- No history of ischemic ECG changes
- No history of chest pain
- No history of arrhythmia
- No history of other clinically significant manifestations of mitral valve prolapse in association with CNS stimulant use
Other
- Not pregnant or nursing
- Negative pregnancy test
- Thyroid stimulating hormone normal
- No known hypersensitivity to modafinil
- No history of psychotic disorder and/or active psychosis
- No history of any chronic medical or psychiatric condition or laboratory abnormality that would preclude study participation or compliance
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Concurrent thalidomide allowed
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Other
- Concurrent narcotics, phenothiazines, or benzodiazepines allowed
- No other concurrent investigational therapy
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
Hva måler studien?
Primære resultatmål
Resultatmål |
---|
Safety, in terms of adverse events and dose-limiting toxicity, as measured by NCI CTC v2.0 at up to 4 weeks after the start of treatment
|
Fatigue as measured by Brief Fatigue Inventory at 2 and 4 weeks after the start of treatment
|
Sekundære resultatmål
Resultatmål |
---|
Mood as measured by Hamilton Rating Scale for Depression at 2 and 4 weeks after the start of treatment
|
Cognitive ability (i.e., memory, fine motor control, fluency, general mental ability, & delayed memory) by Hopkins Verbal Learning Test at 2 and 4 weeks after start of treatment
|
Cognitive ability (i.e., memory, fine motor control, fluency, general mental ability, & delayed memory) by Grooved Pegboard Test at 2 and 4 weeks after start of treatment
|
Cognitive ability (i.e., memory, fine motor control, fluency, general mental ability, & delayed memory) by Controlled Oral Word Association Test from the Multilingual Aphasia Examination at 2 and 4 weeks after start of treatment
|
Cognitive ability (i.e., memory, fine motor control, fluency, general mental ability, & delayed memory) by Trail Making Test A and B at 2 and 4 weeks after start of treatment
|
Cognitive ability (i.e., memory, fine motor control, fluency, general mental ability, & delayed memory) by Recall and Recognition of Word List encoded from the Hopkins Verbal Learning Test at 2 and 4 weeks after start of treatment
|
Functional status as measured by Barthel Index and ECOG performance status at 2 and 4 weeks after the start of treatment
|
Quality of life as measured by Functional Assessment of Cancer Therapy-Br at 2 and 4 weeks after the start of treatment
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Leslie Blackhall, MD, University of Virginia
Studierekorddatoer
Studer hoveddatoer
Studiestart
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CDR0000432953
- UVACC-HIC-10951
- UVACC-30603
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på psykososial vurdering og omsorg
-
Dana-Farber Cancer InstituteFullførtKreft | Kjemoterapi-indusert perifer nevropatiForente stater
-
Medipol UniversityFullførtCAD-test; Barnas Visjon; Fargevurdering; Fargesyn; TyrkiaTyrkia
-
Indiana UniversityIndiana University HealthFullførtMetastatisk kreft | Avansert kreftForente stater
-
SAE OrthopedicsHar ikke rekruttert ennå
-
University of North Carolina, Chapel HillViiV HealthcareFullført
-
Jessa HospitalFullførtArr | Minimalt invasiv hjertekirurgiBelgia
-
University of CincinnatiNational Institute of Nursing Research (NINR)RekrutteringSlag | Familie omsorgspersonerForente stater
-
Karolinska InstitutetRekrutteringBrystneoplasma, treningSverige
-
Duke UniversityNational Institute of Mental Health (NIMH)RekrutteringSelvmordForente stater
-
University of RochesterCharles River AnalyticsFullførtKreftrelaterte kognitive vansker | Kreftrelatert kognitiv sviktForente stater